产品介绍
Product Description
General description
一种非肽硫代苯基甲胺化合物，在MVA（牛痘病毒Ankara）感染（9 µM的IC50<4.5 µM), TLR9 ligand CpG2216 stimulation, VSV-M2 (vesicular stomatitis virus variant 2) infection, or MDA5/TLR3 ligand poly(I:C) stimulation (by >95%抑制）作用下结合干扰素-α（人IFN-α的Kd = 4 µM）并阻止鼠BM-pDC（骨髓源性浆细胞样树突状细胞）培养物中IFN-α和IFNAR相互作用依赖性IFN-α的产生，同时当以无毒浓度（≤4.5 µM）应用时，对相同培养物中IL-12的产生没有抑制性效应。
Packaging
用惰性气体包装
Preparation Note
复溶后，等分并冷冻保存（-20°C）。储备溶液在-20°C下可稳定保存至多6个月。
Other Notes
Geppert, T., et al. 2011.Angew.Chem. Int. Ed.51, 258.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
毒性：标准处理（A）
技术参数
Specifications
| Quality Segment | 100 |
| assay | ≥98% (HPLC) |
| form | solid |
| manufacturer/tradename | Calbiochem® |
| storage condition | OK to freeze,desiccated (hygroscopic),protect from light |
| color | white |
| solubility | DMSO: 50 mg/mL, clear, colorless |
| shipped in | ambient |
| storage temp. | −20°C |
| SMILES string | CNCC1=CC=CC=C1SC2=CC=CC3=C2C=CC=C3.[xHCl] |
